How clinical laboratories can get started in automation—and what to consider when doing so.
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
A brief overview of antimicrobial susceptibility testing, current methods used, and new methods on the horizon.
Polygenic risk scores may offer new screening and risk stratification options for cardiovascular disease—but how valuable are they?
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Artificial intelligence models have a valuable role to play in each phase of the total testing process.
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.
Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.
Artificial intelligence won’t take your job—but what are the real concerns around healthcare AI and its use?
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.